Takeda Pharmaceutical Company Limited (NYSE:TAK – Get Free Report) saw a significant drop in short interest in April. As of April 15th, there was short interest totalling 5,970,000 shares, a drop of 26.5% from the March 31st total of 8,120,000 shares. Currently, 0.2% of the shares of the stock are sold short. Based on an average daily trading volume, of 1,850,000 shares, the short-interest ratio is currently 3.2 days.
Takeda Pharmaceutical Price Performance
Shares of Takeda Pharmaceutical stock traded down $0.04 during trading on Friday, reaching $13.03. The company’s stock had a trading volume of 1,213,476 shares, compared to its average volume of 1,688,482. The stock has a 50-day moving average price of $14.06 and a two-hundred day moving average price of $14.20. The stock has a market capitalization of $41.24 billion, a P/E ratio of 19.74, a price-to-earnings-growth ratio of 2.98 and a beta of 0.53. The company has a current ratio of 1.06, a quick ratio of 0.55 and a debt-to-equity ratio of 0.64. Takeda Pharmaceutical has a one year low of $13.01 and a one year high of $17.11.
Takeda Pharmaceutical (NYSE:TAK – Get Free Report) last posted its quarterly earnings data on Thursday, February 1st. The company reported $0.51 earnings per share for the quarter. The firm had revenue of $7.52 billion during the quarter. Takeda Pharmaceutical had a net margin of 6.90% and a return on equity of 12.57%. As a group, sell-side analysts anticipate that Takeda Pharmaceutical will post 1.5 EPS for the current fiscal year.
Institutional Investors Weigh In On Takeda Pharmaceutical
About Takeda Pharmaceutical
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.
Further Reading
- Five stocks we like better than Takeda Pharmaceutical
- What Are Growth Stocks and Investing in Them
- MarketBeat Week in Review – 4/22 – 4/26
- Using the MarketBeat Dividend Yield Calculator
- 3 Stocks Leading the U.S. Agriculture Comeback
- Investing in Travel Stocks Benefits
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Takeda Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Takeda Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.